145 related articles for article (PubMed ID: 31858531)
21. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
Tian C; Wu H; Li C; Tian X; Sun Y; Liu E; Liao X; Song W
Gene Ther; 2018 Jul; 25(4):312-319. PubMed ID: 29973656
[TBL] [Abstract][Full Text] [Related]
22. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract][Full Text] [Related]
23. Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
Parashar D; Nair B; Geethadevi A; George J; Nair A; Tsaih SW; Kadamberi IP; Gopinadhan Nair GK; Lu Y; Ramchandran R; Uyar DS; Rader JS; Ram PT; Mills GB; Pradeep S; Chaluvally-Raghavan P
Cancer Res; 2020 Dec; 80(24):5554-5568. PubMed ID: 33087324
[TBL] [Abstract][Full Text] [Related]
24. Co-regulation and function of
Barger CJ; Chee L; Albahrani M; Munoz-Trujillo C; Boghean L; Branick C; Odunsi K; Drapkin R; Zou L; Karpf AR
Elife; 2021 Apr; 10():. PubMed ID: 33890574
[TBL] [Abstract][Full Text] [Related]
25. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
26. A Positive Feedback Loop of lncRNA-
Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
[No Abstract] [Full Text] [Related]
27. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway.
Wu Q; Zheng J; Dou C; Qi S
Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292
[TBL] [Abstract][Full Text] [Related]
28. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
29. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
Wei Y; Chen Z; Li Y; Song K
Oncogene; 2024 May; 43(20):1565-1578. PubMed ID: 38561505
[TBL] [Abstract][Full Text] [Related]
30. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
31. LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335.
Wang WJ; Sun K; Li FY; Hui XB; Liu D; Liu J; Wang XD
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):758-765. PubMed ID: 32016979
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
33. [Effects and molecular mechanisms of inhibiting FOXM1 expression on ovarian cancer cell line SKOV3 by Lentiviral vector].
Chen GQ; Yao ZW; Qi HB; Zhang H; Luo Y; Qin XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):29-32. PubMed ID: 22230500
[TBL] [Abstract][Full Text] [Related]
34. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
35. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
Pan H; Zhu Y; Wei W; Shao S; Rui X
World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
[TBL] [Abstract][Full Text] [Related]
37. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.
Han M; Lu H; Han K; Yuan X; Liu S; Wang Y; Zhao J; Liang P; Cheng J
Biochem Biophys Res Commun; 2019 Jul; 515(3):455-461. PubMed ID: 31164201
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
39. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.
Fang Z; Zhang L; Liao Q; Wang Y; Yu F; Feng M; Xiang X; Xiong J
J Exp Clin Cancer Res; 2017 Jan; 36(1):17. PubMed ID: 28114950
[TBL] [Abstract][Full Text] [Related]
40. TCF19 aggravates the malignant progression of colorectal cancer by negatively regulating WWC1.
Du WB; Huang Z; Luo L; Tong SP; Li HQ; Li X; Tong JH; Yao YL; Zhang WB; Meng Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):655-663. PubMed ID: 32016966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
